“The Israeli government is putting up about $25 million over eight years to support about 40 companies that we will admit into the incubators,” Tom Sudow, Cleveland Clinic Innovations’ director of business development, told Cleveland Jewish News.
Cleveland Clinic will connect startups participating in the accelerator with other organizations around the world to which the health system has ties. Mark Stovsky, MD, science and technology innovations officer at Cleveland Clinic, said he sees Israel as a center of real innovation in biomedicine, biotech and digital health.
“We saw an opportunity for the Cleveland Clinic to lend our expertise and to commercialize health-related technologies to help Israeli startup companies get to the market,” Dr. Stovsky told Cleveland Jewish News. “Cleveland Clinic Innovations has vast experience in developing medical technologies and creating successful new companies around those technologies.”
In addition to the $25 million put up by the Israeli government, another $12 million to $15 million is being contributed by other venture capital firms in the U.S. and around the world, according to Mr. Sudow.
More articles on innovation:
CEO of Lucro reflects on company’s beginnings, looks ahead
Mayo Clinic launches innovation competition to license technology
Silicon Valley execs say Trump would be a ‘disaster for innovation’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
